Of 15 IRs, 47% were locoregional only. Among T1ab patients not treated with adjuvant trastuzumab or chemotherapy (n = 171), the 5-year invasive DRFI was 98.2% (95% CI, 94.5% to 99.4%); it was 99.0% ...
The absolute difference in cancer-specific survival for thermal ablation vs surgery for T1a RCC was just 1%. Cancer-specific survival among patients with stage T1a renal cell carcinoma (RCC) is ...
Cancer staging is not just a medical formality but the very foundation of effective cancer care. It's a systematic process that determines how far the disease has progressedâ whether it is confined to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results